We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01346917
First Posted: May 3, 2011
Last Update Posted: October 17, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
HO Kim, MD, Kangbuk Samsung Hospital
  Purpose

The purpose of this study is to determine whether intravenous lidocaine increase the tolerability of early oral feeding after laparoscopic colorectal surgery in patients with colorectal cancer.

  • Degree of nausea/vomiting.
  • Degree of postoperative pain and opioids requirement.
  • Time to first flatus, time to first stool, time to tolerance of regular diet, rate of postoperative complications and duration of postoperative hospital stay.

Condition Intervention
Colorectal Cancer Drug: Lidocaine Drug: Normal saline

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Prospective Randomized Controlled Study for the Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery in Patients With Colorectal Cancer

Resource links provided by NLM:


Further study details as provided by HO Kim, MD, Kangbuk Samsung Hospital:

Primary Outcome Measures:
  • Prevalence of postoperative nausea and vomiting. [ Time Frame: From day of surgery to sixth postoperative day. ]
    Intolerance to early postoperative oral feeding is defined as the patient's having either nausea or vomiting, requiring that the patient be non-per oral status.


Secondary Outcome Measures:
  • Time to first flatus. [ Time Frame: From day of surgery to sixth postoperative day. ]
  • Time to first passage of stool. [ Time Frame: From day of surgery to sixth postoperative day. ]
  • Degree of postoperative pain. [ Time Frame: From day of surgery to sixth postoperative day. ]
  • Postoperative opioid consumption. [ Time Frame: From day of surgery to sixth postoperative day. ]
  • Time to tolerance of regular diet [ Time Frame: From day of surgery to sixth postoperative day. ]
  • Postoperative complications [ Time Frame: From day of surgery to thirtieth postoperative day. ]
  • Duration of postoperative hospital stay. [ Time Frame: From day of surgery until discharge, an expected average of nine days. ]

Enrollment: 77
Study Start Date: April 2011
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lidocaine Drug: Lidocaine
Lidocaine 1mg/kg(loading dose, just before skin incision) and lidocaine(in normal saline, total 240cc) 1mg/kg/hr with ketorolac 90mg for 24hrs.
Placebo Comparator: Placebo Drug: Normal saline
Normal saline 5cc(loading dose, just before skin incision) and normal saline 240cc with ketorolac 90mg for 24hrs.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elective laparoscopic colorectal surgery for colorectal cancer.
  • Age > 18 years.
  • Informed consent.

Exclusion Criteria:

  • Allergy to local anesthetics.
  • Severe cardiovascular, hepatic, or renal diseases.
  • Pregnant or lactating patients.
  • Emergency surgery.
  • American Society of Anesthesiologists (ASA) class IV
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01346917


Locations
Korea, Republic of
Hyung Ook Kim
Seoul, Korea, Republic of, 110-746
Sponsors and Collaborators
Kangbuk Samsung Hospital
Investigators
Principal Investigator: Hyung Ook Kim, M.D Kangbuk Samsung Hospital
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: HO Kim, MD, Assistant professor, Kangbuk Samsung Hospital
ClinicalTrials.gov Identifier: NCT01346917     History of Changes
Other Study ID Numbers: KHO10-1
First Submitted: April 29, 2011
First Posted: May 3, 2011
Last Update Posted: October 17, 2012
Last Verified: October 2012

Keywords provided by HO Kim, MD, Kangbuk Samsung Hospital:
Colorectal cancer
Laparoscopic surgery
Postoperative ileus
Lidocaine
Early oral feeding

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Lidocaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action